Arrowhead opens enrollment in phase Ib study of ARO-HIF2 in advanced clear cell renal cell carcinoma May 13, 2020
Blade Therapeutics begins phase II study of BLD-2660 in hospitalized patients with COVID-19 May 13, 2020
Enabling P-TEFb-dependent transcription of Myc in heart restores cardiomyocyte proliferation May 13, 2020
RSS